000739 Stock Overview
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 4/6 |
Apeloa Pharmaceutical Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.03 |
52 Week High | CN¥19.70 |
52 Week Low | CN¥10.66 |
Beta | -0.0075 |
11 Month Change | 12.00% |
3 Month Change | -5.05% |
1 Year Change | -16.64% |
33 Year Change | -50.62% |
5 Year Change | 37.89% |
Change since IPO | 817.49% |
Recent News & Updates
Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E
Aug 07Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?
Jun 24Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
May 08Shareholder Returns
000739 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -0.5% | -0.2% | -0.7% |
1Y | -16.6% | -12.1% | -19.1% |
Return vs Industry: 000739 underperformed the CN Pharmaceuticals industry which returned -12.1% over the past year.
Return vs Market: 000739 exceeded the CN Market which returned -19.1% over the past year.
Price Volatility
000739 volatility | |
---|---|
000739 Average Weekly Movement | 4.4% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 000739 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000739's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 7,208 | Chun He | www.apeloa.com |
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.
Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary
000739 fundamental statistics | |
---|---|
Market cap | CN¥17.61b |
Earnings (TTM) | CN¥1.06b |
Revenue (TTM) | CN¥11.59b |
16.6x
P/E Ratio1.5x
P/S RatioIs 000739 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
000739 income statement (TTM) | |
---|---|
Revenue | CN¥11.59b |
Cost of Revenue | CN¥8.83b |
Gross Profit | CN¥2.76b |
Other Expenses | CN¥1.70b |
Earnings | CN¥1.06b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 16, 2024
Earnings per share (EPS) | 0.91 |
Gross Margin | 23.81% |
Net Profit Margin | 9.15% |
Debt/Equity Ratio | 14.9% |
How did 000739 perform over the long term?
See historical performance and comparison